Zacks Investment Research on MSN
Synopsys (SNPS) stock falls amid market uptick: What investors need to know
In the latest close session, Synopsys (SNPS) was down 1.59% at $501.39. The stock's performance was behind the S&P 500's ...
D-SNPs are for individuals who qualify for both Medicare and Medicaid, regardless of their overall health status. (Judita Mikalkevičė, Judita Mikalkevičė via Pexels.) The advertiser paid a fee to ...
NEW YORK, NY / ACCESS Newswire / December 3, 2025 / Levi & Korsinsky, LLP releases a Podcast regarding Synopsys, Inc. (SNPS) class action securities lawsuit A Class Action lawsuit was filed on behalf ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results